Terms: = Kidney tumors AND MYC, c-Myc, 4609, ENSG00000136997
408 results:
1. SIRT5 promote malignant advancement of chordoma by regulating the desuccinylation of c-myc.
Jiang M; Huang Z; Chen L; Deng T; Liu J; Wu Y
BMC Cancer; 2024 Mar; 24(1):386. PubMed ID: 38532359
[TBL] [Abstract] [Full Text] [Related]
2. Comparative genomics incorporating translocation renal cell carcinoma mouse model reveals molecular mechanisms of tumorigenesis.
Prakasam G; Mishra A; Christie A; Miyata J; Carrillo D; Tcheuyap VT; Ye H; Do QN; Wang Y; Reig Torras O; Butti R; Zhong H; Gagan J; Jones KB; Carroll TJ; Modrusan Z; Durinck S; Requena-Komuro MC; Williams NS; Pedrosa I; Wang T; Rakheja D; Kapur P; Brugarolas J
J Clin Invest; 2024 Feb; 134(7):. PubMed ID: 38386415
[TBL] [Abstract] [Full Text] [Related]
3. Up-regulation of RAN by MYBL2 maintains osteosarcoma cancer stem-like cells population during heterogeneous tumor generation.
Gao W; Zhou J; Huang J; Zhang Z; Chen W; Zhang R; Kang T; Liao D; Zhong L
Cancer Lett; 2024 Apr; 586():216708. PubMed ID: 38336287
[TBL] [Abstract] [Full Text] [Related]
4. Targeting myc induces lipid droplet accumulation by upregulation of HILPDA in clear cell renal cell carcinoma.
Sainero-Alcolado L; Garde-Lapido E; Snaebjörnsson MT; Schoch S; Stevens I; Ruiz-Pérez MV; Dyrager C; Pelechano V; Axelson H; Schulze A; Arsenian-Henriksson M
Proc Natl Acad Sci U S A; 2024 Feb; 121(7):e2310479121. PubMed ID: 38335255
[TBL] [Abstract] [Full Text] [Related]
5. [Clinicopathological features of intravascular large B-cell lymphoma and collision tumors of five cases].
Liu J; Liu GZ; Xia L; Wang HY; Zhang XF; Liu H
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):22-28. PubMed ID: 38178742
[No Abstract] [Full Text] [Related]
6. Hodgkin Lymphoma: A disease shaped by the tumor micro- and macroenvironment.
Masel R; Roche ME; Martinez-Outschoorn U
Best Pract Res Clin Haematol; 2023 Dec; 36(4):101514. PubMed ID: 38092473
[TBL] [Abstract] [Full Text] [Related]
7. MIOX inhibits autophagy to regulate the ROS -driven inhibition of STAT3/c-myc-mediated epithelial-mesenchymal transition in clear cell renal cell carcinoma.
Meng L; Gao J; Mo W; Wang B; Shen H; Cao W; Ding M; Diao W; Chen W; Zhang Q; Shu J; Dai H; Guo H
Redox Biol; 2023 Dec; 68():102956. PubMed ID: 37977044
[TBL] [Abstract] [Full Text] [Related]
8.
Situ Y; Zhang J; Liao W; Liang Q; Lu L; Xu Q; Chen J; Lu X; Cui Y; Shao Z; Deng L
Front Biosci (Landmark Ed); 2023 Sep; 28(9):196. PubMed ID: 37796681
[TBL] [Abstract] [Full Text] [Related]
9. Gain-of-function mycN causes a megalencephaly-polydactyly syndrome manifesting mirror phenotypes of Feingold syndrome.
Nishio Y; Kato K; Tran Mau-Them F; Futagawa H; Quélin C; Masuda S; Vitobello A; Otsuji S; Shawki HH; Oishi H; Thauvin-Robinet C; Takenouchi T; Kosaki K; Takahashi Y; Saitoh S
HGG Adv; 2023 Oct; 4(4):100238. PubMed ID: 37710961
[TBL] [Abstract] [Full Text] [Related]
10. HSF-1/miR-145-5p transcriptional axis enhances hyperthermic intraperitoneal chemotherapy efficacy on peritoneal ovarian carcinosis.
Di Agostino S; Canu V; Donzelli S; Pulito C; Sacconi A; Ganci F; Valenti F; Goeman F; Scalera S; Rollo F; Bagnato A; Diodoro MG; Vizza E; Carosi M; Rufini B; Federici O; Giofrè M; Carboni F; Muti P; Ciliberto G; Strano S; Valle M; Blandino G
Cell Death Dis; 2023 Aug; 14(8):535. PubMed ID: 37598177
[TBL] [Abstract] [Full Text] [Related]
11. PHF8-GLUL axis in lipid deposition and tumor growth of clear cell renal cell carcinoma.
Peng S; Wang Z; Tang P; Wang S; Huang Y; Xie Q; Wang Y; Tan X; Tang T; Yan X; Xu J; Lan W; Wang L; Zhang D; Wang B; Pan T; Qin J; Jiang J; Liu Q
Sci Adv; 2023 Aug; 9(31):eadf3566. PubMed ID: 37531433
[TBL] [Abstract] [Full Text] [Related]
12. Inhibition of cmyc-MAX transcription factors hetero-dimerization with structurally engineered omomyc to downregulate oncogenic pathways in renal carcinoma.
Li W; Bano F; Khan A; Wei DQ; Alshammari A; Xu B; Wang Y
Comput Biol Med; 2023 Sep; 164():107257. PubMed ID: 37527610
[TBL] [Abstract] [Full Text] [Related]
13. Biallelic Dicer1 Mutations in the Gynecologic Tract of Mice Drive Lineage-Specific Development of DICER1 Syndrome-Associated Cancer.
Wang Y; Chen SY; Ta M; Senz J; Tao LV; Thornton S; Tamvada N; Yang W; Moscovitz Y; Li E; Guo J; Shen C; Douglas JM; Ei-Naggar AM; Kommoss FKF; Underhill TM; Singh N; Gilks CB; Morin GB; Huntsman DG
Cancer Res; 2023 Nov; 83(21):3517-3528. PubMed ID: 37494476
[TBL] [Abstract] [Full Text] [Related]
14. Stage-specific coexpression network analysis of myc in cohorts of renal cancer.
Priyam J; Saxena U
Sci Rep; 2023 Jul; 13(1):11848. PubMed ID: 37481674
[TBL] [Abstract] [Full Text] [Related]
15. Dyskerin and telomerase RNA component are sex-differentially associated with outcomes and Sunitinib response in patients with clear cell renal cell carcinoma.
Yuan H; Qin X; Yang Q; Liu L; Fang Z; Fan Y; Xu D
Biol Sex Differ; 2023 Jul; 14(1):46. PubMed ID: 37434223
[TBL] [Abstract] [Full Text] [Related]
16. Comprehensive analysis reveals the involvement of hsa_circ_0037858/miR-5000-
Nianyong Y; Li G
Aging (Albany NY); 2023 Jun; 15(12):5399-5411. PubMed ID: 37379126
[TBL] [Abstract] [Full Text] [Related]
17. ZNF692 promote proliferation through transcriptional repression of essential genes in clear cell renal carcinoma.
Wang H; Zhao J; He H; Xie X; Dai J; Xu D; Huang X
Biochem Biophys Res Commun; 2023 Sep; 671():255-262. PubMed ID: 37307709
[TBL] [Abstract] [Full Text] [Related]
18. mTOR Regulation of N-myc Downstream Regulated 1 (NDRG1) Phosphorylation in Clear Cell Renal Cell Carcinoma.
Valluri A; Wellman J; McCallister CL; Brown KC; Lawrence L; Russell R; Jensen J; Denvir J; Valentovic MA; Denning KL; Salisbury TB
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298315
[TBL] [Abstract] [Full Text] [Related]
19. c-myc-induced long noncoding RNA MIRE cooperates with hnRNPK to stabilize ELF2 mRNA and promotes clear cell renal cell carcinogenesis.
Li B; Yao B; Guo X; Wang Z; Xie W; Wu X; Wang F; Mei Y
Cancer Gene Ther; 2023 Sep; 30(9):1215-1226. PubMed ID: 37248433
[TBL] [Abstract] [Full Text] [Related]
20. SMARCB1 regulates a TFCP2L1-myc transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance.
Vokshi BH; Davidson G; Tawanaie Pour Sedehi N; Helleux A; Rippinger M; Haller AR; Gantzer J; Thouvenin J; Baltzinger P; Bouarich R; Manriquez V; Zaidi S; Rao P; Msaouel P; Su X; Lang H; Tricard T; Lindner V; Surdez D; Kurtz JE; Bourdeaut F; Tannir NM; Davidson I; Malouf GG
Nat Commun; 2023 May; 14(1):3034. PubMed ID: 37236926
[TBL] [Abstract] [Full Text] [Related]
[Next]
